• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

ArQule - Articles and news items

Phase III study of tivantinib in hepatocellular carcinoma continues

Industry news / 22 March 2016 / Victoria White

ArQule and Daiichi Sankyo today announced that the independent DMC has determined that the METIV-HCC will continue to its final analysis…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +